Tribunal classifies "SYNVISC HYLAN G-F 20" as orthopaedic implant, rejecting differential duty claim

The Tribunal ruled in favor of the appellant, determining that the medical device "SYNVISC HYLAN G-F 20" should be classified under chapter 9021 as an implantable medical device for orthopaedic use, not under chapter 3006 as Gel preparations for surgical operations. The Tribunal dismissed the differential duty and penalty claims, rejecting the Customs authorities' arguments. Additionally, the Tribunal found that the extended period of limitation was not applicable as there was no evidence of wilful suppression by the appellant, leading to the rejection of penalty imposition. The Tribunal upheld the first appellate authority's decision granting exemption benefits and allowed the appellant's appeals.

---

---

Issues:
Classification of imported medical device, differential duty liability, extended period of limitation, penalty imposition, appeal against Order-in-Appeal.

Classification of Imported Medical Device:
The appeals revolve around the classification of a medical device, "SYNVISC HYLAN G-F 20," used for treating Osteoarthritis. The importer claimed classification under Customs Tariff No. 90214090 for exemption benefits. However, the show cause notice alleged misclassification under CTH 3004 9099, proposing re-assessment and duty recovery. The central question was whether the product qualified as a medical device or a pharmaceutical under Customs Tariff headings 9021 or 3006. The appellant argued based on expert opinions and literature that the product functioned as an implant providing functional support, thus falling under chapter 9021 for orthopaedic devices.

Differential Duty Liability and Penalty Imposition:
The issue of differential duty liability and penalty imposition arose due to the disputed classification. The appellant contended that the product should be classified as a medical device, not a pharmaceutical, supported by expert opinions and literature. The Customs authorities argued for classification under chapter heading 3006 as Gel preparations for surgical operations, leading to differential duty demands. The Tribunal analyzed the product's composition, indications, and expert opinions to conclude that it qualified as an implantable medical device under chapter 9021, dismissing the duty and penalty claims.

Extended Period of Limitation and Time Bar:
Another key issue was the invocation of the extended period of limitation based on alleged suppression of product details by the appellant. The Customs authorities sought to impose penalties under section 114A of the Customs Act, 1962. However, the appellant argued that the show cause notice was time-barred as there was no evidence of wilful suppression. The Tribunal agreed, stating that the appellant had correctly declared the product in the invoice and Bill of Entry, and there was no proof of misdeclaration, leading to the rejection of the penalty imposition.

Appeal Against Order-in-Appeal:
The Revenue's appeal challenged the Order-in-Appeal by the first appellate authority, which classified the goods under chapter 90, granting exemption benefits. The Tribunal upheld the first appellate authority's decision, rejecting the Revenue's appeal. The Tribunal allowed the appellant's appeals, providing consequential relief, emphasizing the correct classification of the imported medical device under chapter 9021. The judgment highlighted the importance of expert opinions, literature, and the nature of the product in determining its classification and duty liability.

---